These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Association of anti-acidic ribosomal protein P0 and anti-galectin 3 antibodies with the development of skin lesions in systemic lupus erythematosus. Shi ZR; Tan GZ; Meng Z; Yu M; Li KW; Yin J; Wei KH; Luo YJ; Jia SQ; Zhang SJ; Wu J; Mi XB; Wang L Arthritis Rheumatol; 2015 Jan; 67(1):193-203. PubMed ID: 25307291 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic mechanisms driving the pathogenesis of systemic lupus erythematosus, systemic sclerosis and dermatomyositis. Zhang Y; Maskan Bermudez N; Sa B; Maderal AD; Jimenez JJ Exp Dermatol; 2024 Jan; 33(1):e14986. PubMed ID: 38059632 [TBL] [Abstract][Full Text] [Related]
9. Cutaneous signs of classical dermatomyositis. Auriemma M; Capo A; Meogrossi G; Amerio P G Ital Dermatol Venereol; 2014 Oct; 149(5):505-17. PubMed ID: 25014587 [TBL] [Abstract][Full Text] [Related]
10. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies. Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615 [TBL] [Abstract][Full Text] [Related]
11. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Korn JH; Mayes M; Matucci Cerinic M; Rainisio M; Pope J; Hachulla E; Rich E; Carpentier P; Molitor J; Seibold JR; Hsu V; Guillevin L; Chatterjee S; Peter HH; Coppock J; Herrick A; Merkel PA; Simms R; Denton CP; Furst D; Nguyen N; Gaitonde M; Black C Arthritis Rheum; 2004 Dec; 50(12):3985-93. PubMed ID: 15593188 [TBL] [Abstract][Full Text] [Related]
12. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis]. Lamas Robles C; Mejía Arreguín S; Orozco Medina JH; González Mendoza A Rev Invest Clin; 1984; 36(2):115-9. PubMed ID: 6385174 [No Abstract] [Full Text] [Related]
13. Increased cutaneous T-cell-attracting chemokine levels in sera from patients with systemic sclerosis. Hayakawa I; Hasegawa M; Matsushita T; Yanaba K; Kodera M; Komura K; Takehara K; Sato S Rheumatology (Oxford); 2005 Jul; 44(7):873-8. PubMed ID: 15797972 [TBL] [Abstract][Full Text] [Related]
14. Trichoscopic Signs in Dermatomyositis, Systemic Lupus Erythematosus, and Systemic Sclerosis: A Comparative Study of 150 Patients. Chanprapaph K; Limtong P; Ngamjanyaporn P; Suchonwanit P Dermatology; 2022; 238(4):677-687. PubMed ID: 34879369 [TBL] [Abstract][Full Text] [Related]
15. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Lei W; Luo Y; Lei W; Luo Y; Yan K; Zhao S; Li Y; Qiu X; Zhou Y; Long H; Zhao M; Liang Y; Su Y; Lu Q Scand J Rheumatol; 2009; 38(5):369-74. PubMed ID: 19444718 [TBL] [Abstract][Full Text] [Related]
16. Corticosteroids in Myositis and Scleroderma. Postolova A; Chen JK; Chung L Rheum Dis Clin North Am; 2016 Feb; 42(1):103-18, ix. PubMed ID: 26611554 [TBL] [Abstract][Full Text] [Related]